Selective optimization of side activities: anothe... [J Med Chem. 2004] - PubMed

loading

Successful drug discovery. [Curr Top Med Chem. 2006]
Successful drug discovery.
Swinney DC. Curr Top Med Chem. 2006; 6(5):403-4.
Review Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006. [J Comb Chem. 2007]
Review Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
Dolle RE, Le Bourdonnec B, Goodman AJ, Morales GA, Salvino JM, Zhang W. J Comb Chem. 2007 Nov-Dec; 9(6):855-902. Epub 2007 Sep 19.
From genes to products: innovations in drug discovery. [Drug Discov Today. 2003]
From genes to products: innovations in drug discovery.
Afshar M. Drug Discov Today. 2003 May 1; 8(9):392-4.
Review Automated medicinal chemistry. [Drug Discov Today. 2006]
Review Automated medicinal chemistry.
Koppitz M, Eis K. Drug Discov Today. 2006 Jun; 11(11-12):561-8.
Review Synthetic library design. [Drug Discov Today. 2006]
Review Synthetic library design.
Huwe CM. Drug Discov Today. 2006 Aug; 11(15-16):763-7.

The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology. [Future Med Chem. 2011]
The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology.
McDonald PR, Roy A, Chaguturu R. Future Med Chem. 2011 Jul; 3(9):1101-10.
Review Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. [Arch Toxicol. 2010]
Review Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
Kell DB. Arch Toxicol. 2010 Nov; 84(11):825-89. Epub 2010 Aug 17.
Review High-content drug screening with engineered musculoskeletal tissues. [Tissue Eng Part B Rev. 2010]
Review High-content drug screening with engineered musculoskeletal tissues.
Vandenburgh H. Tissue Eng Part B Rev. 2010 Feb; 16(1):55-64.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Selective optimization of side activities: another way for drug discovery.
Selective optimization of side activities: another way for drug discovery.
J Med Chem. 2004 Mar 11 ;47(6):1303-14.

PubMed
Preferential expression of an alpha-tubulin gene of Arabidopsis in pollen.
Preferential expression of an alpha-tubulin gene of Arabidopsis in pollen.
Plant Cell. 1992 May ;4(5):557-71.

PubMed
Global organization of metabolic fluxes in the bacterium Escherichia coli.
Global organization of metabolic fluxes in the bacterium Escherichia coli.
Nature. 2004 Feb 26 ;427(6977):839-43.

PubMed
A histone variant, H2AvD, is essential in Drosophila melanogaster.
A histone variant, H2AvD, is essential in Drosophila melanogaster.
Mol Biol Cell. 1992 Jun ;3(6):593-602.

PubMed
RNase III enzymes and the initiation of gene silencing.
RNase III enzymes and the initiation of gene silencing.
Nat Struct Mol Biol. 2004 Mar ;11(3):214-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed